Profitelligence Profitelligence · Filing Ledger Open WAT research →

Form 8-K · Current Report · Filed 2026-05-22

Waters Corporation Re-elects Board Members and Approves Key Proposals at Annual Meeting

At the annual meeting of stockholders held on May 21, 2026, Waters Corporation re-elected all nominated directors to its Board, ratified the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm, and approved a non-binding advisory resolution on executive compensation.

Filer
Waters Corporation WAT · NYSE
Filed
Accession
0001193125-26-236929
CIK
0001000697
Signal
Medium impactHealthcare

Details

The re-election of directors received overwhelming support, with over 92% of votes cast in favor for each director. The ratification of the audit firm and the advisory vote on executive compensation also received significant support, with over 85% and 76% of votes cast in favor, respectively.

Items reported

Item events

Reported Item

Board Member Appointed Audit Firm Change Say-on-Pay Approved

Market reaction

Close before filing

$340.99

Next session

-0.7%

Since filing

+10.7%

Latest close

$377.31

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from WAT reporting the same item, with the next session's move:

Insider tape

Within 45 days of this filing, WAT insiders reported 4 Form 4 transactions — net selling of $154K.

Full WAT insider history →

About Waters Corporation

Waters Corporation is a leading entity in the field of analytical instruments and software. It primarily focuses on providing laboratory solutions for a variety of sectors, including pharmaceuticals, healthcare, food and beverage, and chemical analysis. The company's offerings include high-performance liquid chromatography, mass spectrometry systems, and various supporting technologies used for advanced research in life sciences. Waters Corporation is pivotal in enhancing laboratory productivity, offering cutting-edge research tools that assist in drug development, quality control, and environmental testing. Operating globally, it serves a wide array of clients, including academic institutions, government agencies, and private industry players. With its commitment to innovation and precision, Waters Corporation plays a crucial role in advancing scientific and technological progress in multiple critical industries worldwide.

Exchange NYSE Industry Diagnostics & Research Company website ↗

Never miss another WAT filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts